D Maraninchi

11.6k total citations · 2 hit papers
259 papers, 8.5k citations indexed

About

D Maraninchi is a scholar working on Hematology, Oncology and Immunology. According to data from OpenAlex, D Maraninchi has authored 259 papers receiving a total of 8.5k indexed citations (citations by other indexed papers that have themselves been cited), including 121 papers in Hematology, 100 papers in Oncology and 45 papers in Immunology. Recurrent topics in D Maraninchi's work include Hematopoietic Stem Cell Transplantation (93 papers), Acute Myeloid Leukemia Research (46 papers) and Neutropenia and Cancer Infections (30 papers). D Maraninchi is often cited by papers focused on Hematopoietic Stem Cell Transplantation (93 papers), Acute Myeloid Leukemia Research (46 papers) and Neutropenia and Cancer Infections (30 papers). D Maraninchi collaborates with scholars based in France, United States and Switzerland. D Maraninchi's co-authors include Didier Blaise, Patrice Viens, Catherine Faucher, Michel Attal, Mauricette Michallet, David Robert Grimes, Aňa Lluch, François Bertucci, L. Mauriac and Francesco Cognetti and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

D Maraninchi

255 papers receiving 8.2k citations

Hit Papers

Randomized phase II trial of the efficacy and ... 1987 2026 2000 2013 2005 1987 250 500 750 1000
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group.
    2005 1.2k citations D Maraninchi et al. profile →
  2. High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma
    1987 642 citations D Maraninchi et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
D Maraninchi France 47 3.8k 3.7k 1.4k 1.4k 1.3k 259 8.5k
Walter M. Gregory United Kingdom 50 3.9k 1.0× 4.0k 1.1× 797 0.6× 1.3k 1.0× 3.9k 3.1× 203 9.3k
Roy B. Jones United States 43 2.5k 0.7× 3.4k 0.9× 791 0.6× 735 0.5× 970 0.8× 176 6.6k
Martin F. Fey Switzerland 49 3.0k 0.8× 2.1k 0.6× 1.0k 0.7× 1.2k 0.8× 3.1k 2.4× 189 8.0k
F R Appelbaum United States 47 2.9k 0.8× 6.0k 1.6× 1.9k 1.4× 1.2k 0.8× 847 0.7× 99 8.5k
Joseph O. Moore United States 42 1.9k 0.5× 3.3k 0.9× 962 0.7× 997 0.7× 1.8k 1.4× 148 6.6k
D. Crowther United Kingdom 50 4.7k 1.2× 1.5k 0.4× 925 0.7× 3.2k 2.3× 1.2k 0.9× 178 9.3k
Bernhard Wörmann Germany 40 1.9k 0.5× 3.3k 0.9× 648 0.5× 1.6k 1.2× 1.9k 1.5× 173 6.3k
Stefan Suciu Belgium 54 4.7k 1.2× 3.3k 0.9× 2.4k 1.7× 458 0.3× 3.5k 2.7× 235 9.5k
Peter A. Cassileth United States 42 2.3k 0.6× 4.0k 1.1× 917 0.7× 2.1k 1.5× 1.9k 1.5× 127 8.0k
Leo F. Verdonck Netherlands 50 3.1k 0.8× 6.3k 1.7× 2.6k 1.9× 1.5k 1.1× 1.7k 1.4× 158 9.9k

Countries citing papers authored by D Maraninchi

Since Specialization
Citations

This map shows the geographic impact of D Maraninchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D Maraninchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D Maraninchi more than expected).

Fields of papers citing papers by D Maraninchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D Maraninchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D Maraninchi. The network helps show where D Maraninchi may publish in the future.

Co-authorship network of co-authors of D Maraninchi

This figure shows the co-authorship network connecting the top 25 collaborators of D Maraninchi. A scholar is included among the top collaborators of D Maraninchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D Maraninchi. D Maraninchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pujol, Jean Louis, Radj Gervais, Marie‐Laure Tanguy, et al.. (2007). Phase III Double-Blind, Placebo-Controlled Study of Thalidomide in Extensive-Disease Small-Cell Lung Cancer After Response to Chemotherapy: An Intergroup Study FNCLCC cleo04–IFCT 00-01. Journal of Clinical Oncology. 25(25). 3945–3951. 97 indexed citations
2.
Bertucci, François, Pascal Finetti, Nathalie Cervera, et al.. (2006). Gene Expression Profiling Shows Medullary Breast Cancer Is a Subgroup of Basal Breast Cancers. Cancer Research. 66(9). 4636–4644. 218 indexed citations
3.
Chabannon, Christian, Frédérique Penault‐Llorca, Anne Cambon‐Thomsen, et al.. (2006). État des lieux des tumorothèques françaises au premier trimestre de l’année 2005. Bulletin du Cancer. 93(5). 221–227. 2 indexed citations
4.
Jacquemier, Jocelyne, Christophe Ginestier, Jacques Rougemont, et al.. (2005). Protein Expression Profiling Identifies Subclasses of Breast Cancer and Predicts Prognosis. Cancer Research. 65(3). 767–779. 174 indexed citations
5.
Gonçalves, A., A.C. Braud, F. Viret, et al.. (2005). High-dose alkylating agents with autologous hematopoietic stem cell support and trastuzumab in ERBB2 overexpressing metastatic breast cancer: a feasibility study.. PubMed. 25(1B). 663–7. 10 indexed citations
6.
Gonçalvès, Anthony, Patrice Viens, Hagay Sobol, D Maraninchi, & François Bertucci. (2004). Altérations moléculaires des cancers du sein : applications cliniques et nouveaux outils d'analyse. La Revue de Médecine Interne. 26(6). 470–478. 4 indexed citations
7.
Bertucci, François, Anthony Gonçalvès, & D Maraninchi. (2004). [Therapeutic implications of advances in breast cancer biology].. PubMed. 54(8). 865–70. 1 indexed citations
8.
Genre, Dominique, Christel Protière, Geneviève Macquart‐Moulin, & D Maraninchi. (2003). Perception de l’information à travers une brochure sur la recherche biomédicale en cancérologie. Bulletin du Cancer. 90(7). 656–662. 2 indexed citations
9.
Salem, Naji, et al.. (2003). Predictive factors of acute urinary morbidity after iodine-125 brachytherapy for localised prostate cancer: a phase 2 study. Radiotherapy and Oncology. 66(2). 159–165. 39 indexed citations
10.
11.
Cowen, D., Jocelyne Jacquemier, Gilles Houvenaeghel, et al.. (1998). Local and distant recurrence after conservative management of “very low-risk” breast cancer are dependent events: a 10-year follow-up. International Journal of Radiation Oncology*Biology*Physics. 41(4). 801–807. 51 indexed citations
12.
13.
Protière, Christel, Dominique Genre, D. Cowen, et al.. (1997). OP23. Elicitation of preferences and patients participation in the decision making process. European Journal of Cancer. 33. S9–S9. 1 indexed citations
14.
Viens, Patrice, Dominique Genre, M. Resbeut, et al.. (1997). Discordance between physicians' estimations and breast cancer patients' self-assessment of side-effects of chemotherapy: an issue for quality of care. British Journal of Cancer. 76(12). 1640–1645. 68 indexed citations
15.
Faucher, Catherine, Anne‐Gaëlle Le Corroller, Christian Chabannon, et al.. (1996). Autologous Transplantation of Blood Stern Cells Mobilized with Filgrastim Alone in 93 Patients with Malignancies: The Number of CD34+ Cells Reinfused Is the Only Factor Predicting Both Granulocyte and Platelet Recovery. Journal of Hematotherapy. 5(6). 663–670. 43 indexed citations
16.
Chabannon, Christian, Anne‐Gaëlle Le Corroller, Catherine Faucher, et al.. (1995). Patient Condition Affects the Collection of Peripheral Blood Progenitors After Priming with Recombinant Granulocyte Colony-Stimulating Factor. Journal of Hematotherapy. 4(3). 171–179. 28 indexed citations
17.
Bourhis, J. H., Françoise Beaujean, Patrice Viens, et al.. (1993). High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study. European Journal of Cancer. 29(10). 1398–1403. 23 indexed citations
18.
Maraninchi, D, Patrice Viens, Michel Legros, et al.. (1990). Hautes doses d'alkylants et autogreffe de moelle dans les cancers de l'ovaire à mauvais pronostic : une analyse rétrospective de 40 patientes traitées en France. Bulletin du Cancer. 77(2). 149–157.
19.
Resbeut, M., D Maraninchi, Jean‐Gerard Guillet, et al.. (1989). Fractionated total body irradiation and allogeneic bone marrow transplantation for standard risk leukemia. Radiotherapy and Oncology. 16(4). 289–295. 10 indexed citations
20.
Maraninchi, D, Claude Mawas, Denis Guyotat, et al.. (1988). Selective depletion of marrow-T cytotoxic lymphocytes (CD8) in the prevention of graft-versus-host disease after allogeneic bone-marrow transplantation. Transplant International. 1(2). 91–94. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Walter M. Gregory Breakdown of academic impact, for papers by Roy B. Jones Breakdown of academic impact, for papers by Martin F. Fey Breakdown of academic impact, for papers by F R Appelbaum Breakdown of academic impact, for papers by Joseph O. Moore Breakdown of academic impact, for papers by D. Crowther Breakdown of academic impact, for papers by Bernhard Wörmann Breakdown of academic impact, for papers by Stefan Suciu Breakdown of academic impact, for papers by Peter A. Cassileth Breakdown of academic impact, for papers by Leo F. Verdonck
Rankless by CCL
2026